Trials / Sponsors / Prevail Therapeutics
Prevail Therapeutics
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease Parkinson's Disease | Phase 1 | 2024-08-27 |
| Recruiting | A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED) Gaucher Disease, Gaucher Disease, Type 1 | Phase 1 / Phase 2 | 2022-12-20 |
| Active Not Recruiting | Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE) Gaucher Disease, Type 2 | Phase 1 / Phase 2 | 2021-06-29 |
| Active Not Recruiting | Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD Frontotemporal Dementia | Phase 1 / Phase 2 | 2020-11-09 |
| Active Not Recruiting | Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mut Parkinson Disease | Phase 1 / Phase 2 | 2020-01-03 |